ENTITY

ABLBio (298380 KS)

4
Analysis
Health CareSouth Korea
ABLBio, Inc. operates as a drugs development company. The Company develops and manufactures neurodegenerative diseases therapeutic drugs, oncology therapeutic drugs, and other products. ABLBio markets its products throughout Korea.
more
bullishABLBio
03 Jul 2024 03:06

ABL Bio Capital Raise of 140 Billion Won

On 2 July, ABL Bio announced a capital raise worth 140 billion won which involves 5.77 million new shares (10.7% of outstanding shares post capital...

Logo
360 Views
Share
07 Aug 2024 06:00

KRX Short Interest Weekly (Aug 2nd): Sk Hynix, Korea Aerospace, Posco

We analyzed KRX short interest report for the past week and highlighted short interest changes in Sk Hynix, Korea Aerospace, Posco.

Logo
198 Views
Share
10 Jul 2024 06:00

KRX Short Interest Weekly (Jul 5th): Hlb, Posco

We analyzed KRX short interest report for the past week and highlighted short interest changes in Hlb(028300 KS), Posco(005490 KS).

Logo
190 Views
Share
bullishWYSIWYG Studios
09 Nov 2023 03:27

Momentum Trading Opportunities Among Top 50 Stocks in KOSDAQ With Highest Short Interest Ratios

In this insight, we discuss near-term momentum trading opportunities among the top 50 stocks in KOSDAQ with highest short interest ratios.

Logo
396 Views
Share
x